The diversity of Bet v 1–specific IgG4 antibodies remains mostly constant during the course of birch pollen immunotherapy - 04/12/15
Doi : 10.1016/j.jaci.2015.05.025
Brinda Subbarayal, PhD a, b, ∗, Dirk Schiller, PhD c, ∗, Christian Möbs, PhD d, Wolfgang Pfützner, MD d, Beatrice Jahn-Schmid, PhD a, Barbara Gepp, MSc a, Heimo Breiteneder, PhD a, Stefan Vieths, PhD c, Barbara Bohle, PhD a, b 
a Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
b Christian Doppler Laboratory for Immunomodulation, Medical University of Vienna, Vienna, Austria
c Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany
d Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany
| This study was supported by the Christian Doppler Laboratory for Immunomodulation and the Austrian Science Fund, project SFB F4610 and F4608. |
|
| Disclosure of potential conflict of interest: C. Möbs has received research and travel support from the German Research Foundation. W. Pfützner has received research and travel support from the German Research Foundation; is on the ALK-Abelló advisory board on insect venom allergy and house dust mite allergy; and has received lecture fees from Novartis and ALK-Abelló. B. Jahn-Schmid and H. Breiteneder have received research support from the Austrian Science Fund. S. Vieths has received consultancy fees from the Food Allergy Resource and Research Program, Lincoln, Neb; has received honorarium from the Medical University of Vienna for evaluating a PhD thesis; has received research support from Monsanto Company; has received lecture fees from the American Academy of Allergy, Asthma & Immunology, Deutsche Dermatologische Gesellschaft, the Spanish Society of Allergy and Clinical Immunology, Westdeutsche Arbeitsgemeinschaft für pädiatrische Pneumologie und Allergologie e.V., Köln, Germany, Gesellschaft für pädiatrische Allergologie und Umweltmedizin, and Ärzteverband Deutscher Allergologen; received royalties from Schattauer Allergologie Handbuch and Elsevier Nahrungsmittelaller-gien und Intoleranzen; has received travel support from the German Research Foundation, the Federal Institute for Risk Assessment, the Austrian Society for Allergology and Immunology, the European Directorate for the Quality of Medicines and Health Care, the European Academy of Allergy and Clinical Immunology, the World Allergy Organization, Association Monégasque pour le Perfectionnement des Connaissances des Médicins, the Federal Office of Consumer Protection and Food Safety, the German Chemical Society, the Austrian Society for Dermatology and Venerology, AKM Allergiekongress, and the Austrian Food Chemical Society. B. Bohle has received research support from the Austrian Science Fund and the Christian Doppler Laboratory for Immunomodulation. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 136 - N° 6
P. 1680 - décembre 2015 Retour au numéro
Article précédent
- Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis
- Melody C. Carter, Sarah T. Clayton, Hirsh D. Komarow, Erica H. Brittain, Linda M. Scott, Daly Cantave, Donna M. Gaskins, Irina Maric, Dean D. Metcalfe
- Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapy
- Alan Winston, Sophie Jose, Martin Fisher, John Walsh, Mark Nelson, Richard Gilson, Frank Post, Margaret Johnson, Clifford Leen, David Chadwick, Phillip Hay, Jillian Pritchard, Anjum Tariq, Caroline Sabin, UK Collaborative HIV Cohort Study
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?